1.. Introduction {#S1}
================

The COVID-19 pandemic has led to millions of infections worldwide, but the relative contribution of different modes of transmission of its causative agent, SARS-CoV-2, remains elusive. Transmission is thought to occur primarily via large respiratory droplets and close contact, but transmission via aerosols and fomites has also been suggested \[[@R1]--[@R4]\]. In this context, and considering the non-negligible environmental stability of SARS-CoV-2 on different surfaces \[[@R5], [@R6]\], there is a need for rapid and effective decontamination methods. Clearly, decontamination is a concern for all other infectious agents as well.

Heat is widely used for the inactivation of various infectious agents, notably viruses \[[@R7]\]. It is thought to inactivate viruses mainly by denaturing the secondary structures of proteins and other molecules, resulting in impaired functions \[[@R8]\]. It is used for the decontamination of various materials, such as personal protective equipment (PPE), examination and surgery tools, culture and transportation media, or biological samples \[[@R9]--[@R12]\]. Regarding SARS-CoV-2 in particular, moist heat is advised by the United States Centers for Disease Control and Prevention as a virus inactivation method \[[@R13]\].

In this context, several studies have tested the effectiveness of heat to inactivate coronaviruses on various household surfaces, PPE, culture and transportation media, or blood products \[[@R11], [@R14]--[@R19]\]. The same type of procedures are used for many other viruses such as influenza viruses, hepatitis viruses, parvoviruses and human immunodeficiency viruses \[[@R20]--[@R23]\]. Ways to apply heat treatments vary, notably settings can use dry versus moist heat and allow different levels of heat transfer (e.g., oven versus heat block, the latter theoretically allowing a higher heat transfer) and different levels of evaporation (e.g., samples in closed vials versus in open plates, two containers classically used in laboratories). Studies often do not report detailed procedures; this may make it difficult to interpret and replicate findings or to translate them into safe guidelines if inactivation rates differ by procedure.

Here, we assess the impact of treatment procedure on SARS-CoV-2 inactivation by heat. We studied dry heat treatment applied to a liquid specimen (virus suspension in cell culture medium), keeping temperature constant (at 70°C) but allowing different degrees of heat transfer (using a dry oven or a heat block) and evaporation (placing samples in closed vials, covered plates or uncovered plates). We then compared the inactivation rates and half-lives of SARS-CoV-2 under different procedures.

2.. Material and Methods {#S2}
========================

(a). Laboratory experiments {#S3}
---------------------------

We used the SARS-CoV-2 strain HCoV-19 nCoV-WA1--2020 (MN985325.1) \[[@R24]\] for all our experiments. We prepared a solution of SARS-CoV-2 in Dulbecco's Modified Eagle Medium (DMEM) cell culture medium (Sigma-Aldrich). We applied four distinct heat-treatment procedures: (1) an uncovered 24-well plate, (2) a covered 24-well plate (using an unsealed plastic lid), (3) a set of closed 2 mL vials in a dry oven at 70°C, and (4) a set of closed 2 mL vials in a heat block containing water at 70°C. For each procedure, we placed samples of 1 mL of solution in plate wells or vials before heat treatment, and removed them at 10, 20, 30 and 60 min from the uncovered 24-well plate, or at 30, 60 and 90 min for the three other procedures.

For each experiment, we took a 0 min time-point measurement prior to exposing the specimens to the heat treatment. At each collection time-point, samples were transferred into a vial and frozen at −80°C until titration (or directly frozen for experiments conducted in vials). We performed three replicates for each inactivation procedure. We quantified viable virus contained in the collected by end-point titration on Vero E6 cells as described previously \[[@R11]\].

(b). Statistical analyses {#S4}
-------------------------

We quantified the inactivation rate of SARS-CoV-2 in DMEM following different heat-treatment procedures by adapting a Bayesian approach described previously \[[@R11]\]. Briefly, we inferred virus titers from raw endpoint titration well data by modeling well infections as a Poisson single-hit process \[[@R25]\]. Then, we estimated the decay rates of viable virus titer following treatment using a regression model. This modeling approach allowed us to account for differences in initial virus titers (0 min time-point) across samples as well as other sources of experimental noise. The model yields posterior distributions for the viral decay rates under various treatment procedures-that is, estimates of the range of plausible values for these parameters given our data, with an estimate of the overall uncertainty \[[@R26]\]. We then calculated half-lives from the estimated exponential decay rates. We analyzed data obtained under different treatment procedures separately. We placed weakly informative prior distributions on mean initial virus titers and log virus half-lives. The complete model is detailed is detailed in the [Supplementary Information](#SD1){ref-type="supplementary-material"} ([SI](#SD1){ref-type="supplementary-material"}, end of this document).

We estimated virus titers and model parameters by drawing posterior samples using Stan \[[@R27]\], which implements a No-U-Turn Sampler (a form of Markov Chain Monte Carlo), via its R interface RStan. We report estimated titers and model parameters as the median \[95% credible interval\] of their posterior distribution. We assessed convergence by examining trace plots and confirming sufficient effective sample sizes and $\hat{R}$ values for all parameters. We confirmed appropriateness of prior distributions with prior predictive checks and assessed goodness of fit by plotting regression lines against estimated titers and through posterior predictive ([SI](#SD1){ref-type="supplementary-material"}, [Fig. 3](#SD1){ref-type="supplementary-material"}--[5](#SD1){ref-type="supplementary-material"}).

3.. Results {#S5}
===========

The inactivation rate of SARS-CoV-2 differed sharply across the four heat-treatment procedures, leading to large differences in the time until the virus dropped below detectable levels despite comparable initial quantities of virus (mean initial titer ranging from 4.3 \[3.7, 4.7\] to 4.8 \[4.3, 5.1\] log~10~ TCID~50~*/*mL). We could not detect viable virus in DMEM after 30 min of treatment (the earliest time-point) in closed vials heated either in a heat block or in a dry oven; we could not detect viable virus after 90 min in covered plates ([Fig. 1](#F1){ref-type="fig"}). In uncovered plates, we observed an reduction of viral titer in DMEM of approximately 1 log~10~ TCID~50~*/*mL after 60 min.

We estimated inactivation rates from the experimental data, and converted these to half-lives to compare the four procedures. SARS-CoV-2 inactivation in DMEM was rapid in closed vials, using either a heat block or a dry oven (half-lives of 0.86 \[0.09, 1.77\] and 1.91 \[0.10, 1.99\] min, respectively), compared to the other treatment procedures ([Fig. 2](#F2){ref-type="fig"}). Inactivation rate was intermediate in covered plates (half-life of 3.94 \[3.12, 5.01\] min) and considerably slower in uncovered plates (37.04 \[12.65, 869.82\] min).

4.. Discussion {#S6}
==============

Using SARS-CoV-2 as an illustration, we demonstrate that the choice of procedure has a considerable impact on virus inactivation from liquid specimen using dry heat. In liquid specimens (here viral suspension in cell culture medium), virus half-life can vary from 0.86 min (\[0.09, 1.77\]) in closed vials to 37.0 min (\[12.65, 869.82\]) in uncovered plates treated with dry heat at 70°C. The rapid virus inactivation in closed vials subject to dry heat at 70°C agrees with previously reported results for inactivation of SARS-CoV-2 in virus transportation medium \[[@R29]\], SARS-CoV-1 in human serum \[[@R14]\], and MERS-CoV \[[@R15]\] and canine coronavirus in cell culture medium \[[@R18]\] for instance. All showed a loss of infectivity on the order of 10^4−6^ TCID~50~ after 5--10 min at 65--75°C. None of these studies report sufficient details on their protocol to know which of our tested procedures corresponds most closely to their approach.

Our findings suggest a critical role for evaporation in determining the rate of virus inactivation using dry heat, bringing fundamental insights on the mechanisms by which temperature and humidity affect viral stability. There are several mechanisms by which evaporation can impact the effectiveness of heat treatments to inactivate viruses. First, evaporation can induce a local drop in temperature due to the enthalpy of vaporization of water, limiting the effect of heat itself. Second, evaporation can lead to modifications of the virion's solute environment. Salts and proteins become more concentrated as the solvent evaporates, and under certain conditions crystallization can occur \[[@R30]\]. Evaporation can also modify ambient pH \[[@R30]\]. These processes do not depend solely on temperature; factors such such as initial composition of the medium (\[[@R17], [@R31]\]) and ambient relative humidity \[[@R30]\] play a role. Furthermore, the effects of salinity and pH on viral infectivity are not fully characterized, and hence are difficult to predict. Better understanding the impact of temperature and humidity on viral stability is critical not only for designing efficient decontamination protocols but also for predicting viral stability under different environmental conditions-with consequences for real-world transmission \[[@R32], [@R33]\]. Heat transfer could potentially also play a role in determining the rate of virus inactivation using dry heat, but our experimental design did not allow us to explore this hypothesis since virus inactivation was fast in closed vials regardless of whether they were exposed to heat using an dry oven or a heat block.

Given the substantial effect of heat-treatment procedure on virus inactivation rates, it is critical to consider procedure closely when comparing inactivation rates between studies or producing guidelines for decontamination. In particular, our results show that protocols in open containers or uncovered surfaces lead to a much slower viral inactivation, at least in bulk medium. Hence, meta-analyses of the effect of temperature on virus inactivation integrating together data collected following different procedures can lead to false conclusions. This observation also has important implications regarding decontamination practices using heat treatment, as it highlights that inactivation rates reported by studies conducted on closed vials are likely not representative of inactivation rates one can expect using a dry oven to decontaminate a piece of equipment. As a matter of fact, the half-life of SARS-CoV-2 on stainless steel and N95 fabric treated by heat (70°C) using a dry oven, without any container susceptible to limit evaporation, has been estimated at approximately 9 and 5 min respectively \[[@R11]\]. These values are on the same order of magnitude as the half-life of the virus in DMEM exposed to heat treatment in a covered plate (3.94 \[3.12, 5.01\] min), and considerably higher than the the half-life of the virus in DMEM exposed to heat treatment in a closed vial. Inactivation rates reported by studies conducted on closed vials should not be used to directly inform decontamination guidelines of pieces of equipment that can not be treated using the same exact procedure.

Unfortunately, many studies on heat treatment for virus inactivation do not report the exact procedures under which the samples were exposed to heat, in particular whether they were in closed, covered or uncovered containers), limiting the possibility to compare inactivation rates between studies or inform decontamination guidelines. More generally, considering all the different factors that can impact virus inactivation rate, we recommend to use decontamination procedures validated specifically for the concerned setting rather than to translate experimental studies into decontamination guidelines, especially when experimental protocols are elusive.

This study focuses exclusively on virus inactivation by heat. Other factors have been suggested to modulate virus inactivation rate in liquid specimens, including pH, salinity and protein concentration \[[@R17], [@R30], [@R34]\]; we consider these only implicitly, via the possible effects of evaporation. In addition, the impact of procedure is likely to differ across microbes, in particular when considering enveloped versus non-enveloped viruses, or viruses versus bacteria \[[@R30]\]. Finally, another critical aspect to consider is the potential impact on the integrity of the decontaminated equipment or specimen, notably for PPE and biological samples \[[@R11], [@R35], [@R36]\]. Any effort to translate inactivation rates (or even relative patterns) from one setting to another should thus be undertaken cautiously, accounting for these factors. Nevertheless, our findings highlight the importance of careful consideration of treatment procedures, notably regarding the degree of permitted evaporation.
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![Inactivation of SARS-CoV-2 by heat treatment under different procedures. SARS-CoV-2 in DMEM cell culture medium was exposed to 70°C heat. Samples were placed in uncovered or covered 24-well plates, or in closed 2 mL vial before heat treatment using a dry oven or a heat block. Samples were then collected at indicted time-points during heat treatment. Viable virus titer estimated by end-point titration is shown in TCID~50~*/*mL media on a logarithmic scale. Points show estimated titers for each collected sample; vertical bar shows a 95% credible interval. Time-points with no positive wells for any replicate are plotted as triangles at the approximate single-replicate detection limit of the assay (LOD; denoted by a black dotted line at 10^0.5^ TCID~50~*/*mL media) to indicate that a range of sub-LOD values are plausible. Lines show predicted decay of virus titer over time (10 random draws per datapoint from the joint posterior distribution of the exponential decay rate, i.e. negative of the slope, and datapoint intercept, i.e. initial virus titer).](nihpp-2020.08.10.242206-f0001){#F1}

![Half-life of SARS-CoV-2 in DMEM cell culture medium exposed to 70°C heat under different procedures. Quantile dotplots \[[@R28]\] of the posterior distribution for half-life of viable virus under each different heat-treatment procedure. Half-lives were calculated from the estimated exponential decay rates of virus titer ([Fig. 1](#F1){ref-type="fig"}) and plotted on a logarithmic scale. For each distribution, the black dot shows the posterior median estimate and the black line shows the 95% credible interval.](nihpp-2020.08.10.242206-f0002){#F2}
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